Department of Neurology, Charité Universitätsmedizin Berlin
Berlin, Germany
NCT Number: NCT01219244
The study will investigate whether dietary modification could provide positive effects on brain functions in elderly people with mild cognitive impairment.
Looking for future studies?
Notify Me50 year–80 year
All sexes
Interventional
Phase 2 / Phase 3
Berlin, Germany
The age-related degradation of cognitive functions even to the point of neurodegenerative disorders such as Alzheimer's disease are a growing public-health concern with devastating effects.
Referring to animal data, empirical studies, and pilot human trials, dietary modification (caloric restriction, omega-3 fatty acids and resveratrol) should improve cognitive functions such as learning and memory. To test this hypothesis, the researchers study general brain functions in elderly subjects (50-80 years old) with mild cognitive impairment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
6 months of caloric restriction (15 %)
6 months of omega-3 supplementation
6 months of resveratrol supplementation
6 months of placebo intake
most effective dietary intervention plus physical and cognitive training
most effective dietary intervention plus control
Time frame: Prior to intervention and after 6 months of intervention
Time frame: Prior to intervention and after 6 months of intervention
Time frame: Prior to intervention and after 6 months of intervention
Charite University, Berlin, Germany
Other
Enhancing Memory Functions in Patients With Mild Cognitive Impairment by Dietary Interventions and in Combination With Exercise and Cognitive Training - Proof of Concept and Mechanisms
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05584241
Alzheimer Disease, Amnestic Mild Cognitive Disorder
Ann Arbor, Michigan, United States
View Trial DetailsNCT05564715
Amnestic Mild Cognitive Impairment - aMCI, Cognition Disorders
Dallas, Texas, United States
View Trial DetailsNCT06335953
Alzheimer Disease, Alzheimer's Disease and Related Dementias
Baltimore, Maryland, United States
View Trial DetailsNCT05313529
Cognition Disorders, Cognitive Dysfunction
Changzhou, Jiangsu, China
View Trial Details